Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer
Health Populi
AUGUST 16, 2021
bn for patient spending on branded drug cost-sharing after accounting for manufacture-financed support. Exhibit 3 shows these costs for each stakeholder, totaling $93 billion. These are, in order of magnitude: $35.8 bn for the cost of physician practice time interactive with payers about prior authorization.
133 
Let's personalize your content